Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
Rossi
G
G
Istituto di Chirurgia Sperimentale e dei Trapianti, IRCCS Ospedale Maggiore, Milano, Italy.
Reggiani
P
P
Orsenigo
R
R
Leoni
L
L
Caccamo
L
L
Doglia
M
M
Gatti
S
S
Maggi
U
U
Paone
G
G
Galmarini
D
D
Fassati
L R
LR
D000284:Administration, Oral; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D012189:Retrospective Studies; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone